Ethereum’s (ETH) price is experiencing a pullback towards the $1,103 support level as a result of Bitcoin’s recent dip. But is the second-largest cryptocurrency by market cap a good buy at the moment? Fundamental analysis: whales buying discounted Ether Ethereum’s current fundamental outlook is considered as fairly bullish, especially with more analysts coming out with multi-thousand dollar price projections. On top of that, Ethereum’s use as a platform has expanded greatly, and new well thought out projects are coming out to the public more often than before. Are you looking for fast-news, hot-tips and market analysis? Sign-up for the Invezz newsletter, today. Recent analyses have shown that, as long as Ether stays above the $908mark, the cryptocurrency will remain bullish. Additionally, institutional investors and ETH “whales” are taking price corrections such as the most recent one to accumulate more Ether at a discounted price. ETH managed to lost 8.33% week-over-week. BTC scored a loss of 6.40% in the same period, slightly outperforming ETH in the past week. At the time of writing, ETH is trading for $1,153, representing a price increase of 83.58% when compared to the previous month’s value. Ethereum is the second-largest cryptocurrency by market cap, with a current total market value of $130.2 billion. ETH/USD technical analysis: Ethereum’s downside is well-guarded Ethereum (ETH) has managed to find strong resistance in the $908 support level and the 21-day exponential moving average, which prompted another leg up caused by the bulls buying ETH at a discount. The
Electromed, Inc. ("Electromed” or the "Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Mike MacCourt, Chief Financial Officer, are scheduled to participate in the 2020 Colliers Institutional Investor Conference, which will be held virtually, on Thursday, September 10, 2020.
About Electromed, Inc.
Electromed manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. The Company is headquartered in New Prague, Minnesota and was founded in 1992. Further information about Electromed can be found at www.smartvest.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200826005713/en/
F5 Networks announced the acquisition of cloud-management Volterra startup for $500 million Volterra was founded only last year when it raised $50 million On Friday, shares closed 6.19% higher after surging more than 11% to trade above $200 for the first time ever Shares of F5 Networks (NASDAQ: FFIV) soared over 6% on Friday to exceed the $200.00 mark for the first time ever. The company announced the acquisition of Volterra startup for $500 million. Fundamental analysis: Volterra to be integrated F5 Networks said it will pay $440 million in cash and $60 million in deferred and unvested incentive payments to acquire could-management startup Volterra. Interestingly, Volterra was founded only last year when it raised $50 million. Are you looking for fast-news, hot-tips and market analysis? Sign-up for the Invezz newsletter, today. According to François Locoh-Donou, the president and chief executive of F5 Networks, said his company will work to integrate Volterra’s f products in his company’s portfolio. “With Volterra, we advance our Adaptive Applications vision with an Edge 2.0 platform that solves the complex multi-cloud reality enterprise customers confront. Our platform will create a SaaS solution that solves our customers’ biggest pain points,” he said.
